PMDA drug package insert
ミルマグ錠350mg
PMDA Prescription drug · エムジーファーマ株式会社 · package insert Aug 8, 2023
Key facts
| Brand names | ミルマグ錠350mg |
|---|---|
| Nonproprietary names | 水酸化マグネシウム |
| Companies | 製造販売元／エムジーファーマ株式会社, 発売元／共和薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 緩下・制酸剤 |
| Therapeutic category codes | 872344, 872355 |
| YJ codes | 2344003F1038 |
| Approval numbers | 22100AMX01311000 |
| Package insert edition | 第1版 |
| Package insert date | Aug 8, 2023 |
| PMDA document key | 170510_2344003F1038_1 |
| PMDA company code | 170510 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: